Arcus Biosciences Inc.

02/15/2025 | Press release | Distributed by Public on 02/15/2025 14:45

New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer